BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Woodward S. The use of Resolor (prucalopride) for chronic constipation in women. Br J Nurs 2012;21:982, 984-6. [PMID: 23123655 DOI: 10.12968/bjon.2012.21.16.982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Paquette IM, Varma M, Ternent C, Melton-meaux G, Rafferty JF, Feingold D, Steele SR. The American Society of Colon and Rectal Surgeons’ Clinical Practice Guideline for the Evaluation and Management of Constipation. Diseases of the Colon & Rectum 2016;59:479-92. [DOI: 10.1097/dcr.0000000000000599] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
2 Leelakusolvong S, Ke M, Zou D, Choi SC, Tack J, Quigley EM, Liu A, Kim JY. Factors predictive of treatment-emergent adverse events of prucalopride: an integrated analysis of four randomized, double-blind, placebo-controlled trials. Gut Liver 2015;9:208-13. [PMID: 25534573 DOI: 10.5009/gnl14290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]